WallStreetZenWallStreetZen

NYSE: NVS
Novartis Ag Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Novartis Ag revenue was $51.72B for the trailing 12 months ending Dec 31, 2024, with -17.2% growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $13.6B, up 2.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NVS annual revenue was $51.7B, with 10.8% growth year-over-year.

NVS past revenue growth

How has NVS's revenue growth performed historically?

Company
10.85%
Industry
14.44%
Market
20.87%
NVS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
NVS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
NVS's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

NVS revenue history

Current Revenue
$51.7B
Current Earnings
$11.9B
Current Profit Margin
23.1%
NVS's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

Be the first to know when NVS announces revenue.

NVS Revenue History By Year

NVS Yearly RevenueNVS RevenueNVS ChangeNVS Revenue Growth
2024-12-31$51.72B$5.06B+10.85%
2023-12-31$46.66B$3.20B+7.36%
2022-12-31$43.46B-$513.00M-1.17%
2021-12-31$43.97B-$5.92B-11.87%
2020-12-31$49.90B$1.22B+2.51%
2019-12-31$48.68B$2.58B+5.59%
2018-12-31$46.10B$2.70B+6.21%
2017-12-31$43.40B-$6.03B-12.20%
2016-12-31$49.44B-$951.00M-1.89%
2015-12-31$50.39B-$3.25B-6.05%
2014-12-31$53.63B$918.00M+1.74%
2013-12-31$52.72B$745.00M+1.43%
2012-12-31$51.97B-$7.40B-12.47%
2011-12-31$59.38B$7.81B+15.15%
2010-12-31$51.56B$6.46B+14.32%
2009-12-31$45.10B$2.52B+5.92%
2008-12-31$42.58B$3.64B+9.34%
2007-12-31$38.95B$3.84B+10.94%
2006-12-31$35.11B$5.35B+17.99%
2005-12-31$29.75B$2.48B+9.08%
2004-12-31$27.28B$2.35B+9.41%
2003-12-31$24.93B$4.05B+19.41%
2002-12-31$20.88B$2.12B+11.27%
2001-12-31$18.76B-$3.07B-14.06%
2000-12-31$21.83B-$10.63B-32.75%
1999-12-31$32.47B$763.00M+2.41%
1998-12-31$31.70BN/AN/A

1 of 2

Novartis Ag Revenue FAQ

What was NVS's revenue last quarter?

On Invalid Date, Novartis Ag (NYSE: NVS) reported Q4 2024 revenue of $13.56 billion up 15.13% year over year. In the same quarter last year, Novartis Ag's revenue was $11.78 billion.

What was Novartis Ag's revenue in 2024?

Novartis Ag's annual revenue for the twelve months ending Dec 31, 2024 was $51.72 billion, a 10.85% increase year over year.

How much does Novartis Ag make in a day?

Based on Novartis Ag annual revenue for the past five years, NVS makes an average of $129,158,904.11 per day.

What was Novartis Ag's annual revenue growth in the past year?

As of Q2 2025, Novartis Ag's revenue has grown 10.85% year over year. This is 3.59 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 14.44%. Novartis Ag's revenue in the past year totaled $51.72 billion.

How much does Novartis Ag make in a year?

Novartis Ag's revenue by year for the past five years is:
  • Novartis Ag's revenue for the twelve months ending Dec 31, 2024 was $51.72 billion, a 10.85% increase year over year.
  • Novartis Ag's annual revenue for Dec 31, 2023 was $46.66 billion, a 7.36% increase from 2022.
  • Novartis Ag's annual revenue for 2022 was $43.46 billion, a 1.17% decrease from 2021.
  • Novartis Ag's annual revenue for 2021 was $43.97 billion, a 11.87% decrease from 2020.
  • Novartis Ag's annual revenue for 2020 was $49.90 billion, a 2.51% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.